The NIH Trial to Assess Chelation Therapy (TACT): an unethical s...

Courtesy Health Care Renewal  Fri, 05/16/2008 - 07:00

Two occasional HCR bloggers are co-authors of an article published this week:

Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned
Kimball C.

Atwood IV, MD; Elizabeth Woeckner, AB, MA; Robert S. Baratz, MD, DDS, PhD; Wallace I. Sampson, MD
Medscape J Med. 2008;10(5):115.

©2008 Medscape
Posted 05/13/2008
Abstract:

The National Institutes of Health (NIH) Trial to Assess Chelation Therapy (TACT) was begun in 2003 and is expected to be...

Sponsors
Tags:

 

Related items

University Hospitals Case Medical Center recognized by American...
(University Hospitals of Cleveland) University Hospitals Case Medical Center has received the Get With the Guidelines Gold Performance Achievement...

Heart Imaging Tool Under the Microscope
There is not enough evidence to prove that computed tomography angioplasty is a safe and effective screening tool for coronary artery disease in...

Still puzzling: Best care for the frail and elderly with...
(Duke University Medical Center) A new study from Duke University Medical Center finds that patients treated solely with medications after suffering...

Time To Talk About CAM
The National Center for Complementary and Alternative Medicine (NCCAM), part of the National Institutes of Health (NIH), has launched Time to Talk,...

African Americans have 5 times higher amputation rate
(Northwestern University) A new study from Northwestern University's Feinberg School of Medicine has found people in African American communities in...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com